Hovenia dulcis (Dihydromyricetin)

Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Hovenia dulcis (Dihydromyricetin).

Dihydromyricetin functions as a potent flavonoid modulator of GABA-A receptors and an inducer of ethanol-metabolizing enzymes, primarily utilized for mitigating alcohol-induced hepatotoxicity and neuro-excitability.

Verified Molecular Profiling (NIH PubChem)

PubChem CID

161241

Molecular Weight

193.14 g/mol

XLogP3 (Lipophilicity)

1.2

IUPAC Name

1-[azidomethyl(ethoxy)phosphoryl]oxyethane

Pharmacokinetic Synergies & Enhancers

Proven Synergy Pairings

Milk Thistle for synergistic hepatoprotection via glutathione pathway stabilization
Ginger Extract for adjunctive mitigation of alcohol-induced gastrointestinal distress

Biological Formulation Enhancers

Piperine for inhibition of P-glycoprotein-mediated efflux to increase systemic bioavailability
Lecithin for lipid-based micellar solubilization of the hydrophobic flavonoid structure

Delivery System Constraints & Modeling

Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Hovenia dulcis (Dihydromyricetin) across standard consumer modalities.

💊 Standard Capsules

The high bulk density and potential hygroscopicity of concentrated Hovenia extracts require precise excipient selection to prevent clumping and ensure uniform flow during encapsulation.

🍬 Gummy & Pectin Formats

Dihydromyricetin exhibits a distinct bitter profile and poor solubility in aqueous pectin matrices, necessitating advanced masking agents and emulsifiers to prevent precipitation and textural graininess.

🔬 Thin-Film Oral Strips

The typical therapeutic dose of 300-600mg significantly exceeds the standard 50mg payload capacity of thin-film polymers, making it unsuitable for single-strip delivery.

For Brand Founders

Formulate with Hovenia dulcis (Dihydromyricetin)

Ready to launch a product featuring Hovenia dulcis (Dihydromyricetin)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.

Build Science-Backed Formulation

Efficacy Evidence

Maximize Hovenia dulcis (Dihydromyricetin) Bioavailability

Need absolute proof that your Hovenia dulcis (Dihydromyricetin) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.

Simulate Bioavailability

For R&D Labs & CDMOs

Hovenia dulcis (Dihydromyricetin) Degradation Testing

Is your Hovenia dulcis (Dihydromyricetin) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.

Model Active Degradation